Financial Snapshot

Revenue
$9.608B
TTM
Gross Margin
75.59%
TTM
Net Earnings
$1.615B
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
125.91%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$16.36B
Q3 2024
Cash
Q3 2024
P/E
14.52
Nov 29, 2024 EST
Free Cash Flow
$1.768B
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990
Revenue $9.836B $10.17B $10.98B $13.44B $14.38B $13.45B $12.27B $11.45B $10.76B $9.703B $6.932B $5.516B $5.049B $4.716B $4.377B $4.098B $3.172B $2.683B $2.423B $2.212B $679.0M $404.0M $273.0M $155.0M $118.0M $87.00M $45.00M $30.00M $24.00M $7.000M $13.00M $5.000M $6.000M $7.000M
YoY Change -3.32% -7.36% -18.32% -6.49% 6.88% 9.61% 7.21% 6.36% 10.93% 39.97% 25.66% 9.27% 7.04% 7.75% 6.81% 29.19% 18.23% 10.73% 9.54% 225.77% 68.07% 47.99% 76.13% 31.36% 35.63% 93.33% 50.0% 25.0% 242.86% -46.15% 160.0% -16.67% -14.29% 16.67%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990
Revenue $9.836B $10.17B $10.98B $13.44B $14.38B $13.45B $12.27B $11.45B $10.76B $9.703B $6.932B $5.516B $5.049B $4.716B $4.377B $4.098B $3.172B $2.683B $2.423B $2.212B $679.0M $404.0M $273.0M $155.0M $118.0M $87.00M $45.00M $30.00M $24.00M $7.000M $13.00M $5.000M $6.000M $7.000M
Cost Of Revenue $2.533B $2.278B $2.110B $1.805B $1.955B $1.816B $1.630B $1.479B $1.240B $1.171B $857.7M $545.5M $466.8M $400.3M $382.0M $402.0M $335.0M $274.0M $374.0M $554.0M $285.0M $1.000M $0.00 $2.000M $14.00M $20.00M $19.00M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $7.302B $7.895B $8.872B $11.64B $12.42B $11.64B $10.64B $9.970B $9.523B $8.532B $6.075B $4.971B $4.582B $4.316B $3.995B $3.696B $2.836B $2.409B $2.049B $1.657B $394.0M $403.0M $273.0M $153.0M $104.0M $67.00M $26.00M $30.00M $24.00M $7.000M $13.00M $5.000M $6.000M $7.000M
Gross Profit Margin 74.24% 77.61% 80.79% 86.57% 86.4% 86.5% 86.72% 87.08% 88.48% 87.93% 87.63% 90.11% 90.76% 91.51% 91.27% 90.19% 89.41% 89.79% 84.56% 74.91% 58.03% 99.75% 100.0% 98.71% 88.14% 77.01% 57.78% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990
Selling, General & Admin $2.550B $2.404B $2.674B $2.505B $2.375B $2.106B $1.934B $1.947B $2.113B $2.232B $1.712B $1.277B $1.056B $1.032B $911.0M $925.0M $776.0M $685.0M $645.0M $580.0M $175.0M $88.00M $51.00M $28.00M $19.00M $17.00M $11.00M $7.000M $6.000M $5.000M $4.000M $3.000M $2.000M $1.000M
YoY Change 6.08% -10.12% 6.78% 5.47% 12.74% 8.91% -0.65% -7.88% -5.34% 30.38% 34.02% 20.96% 2.38% 13.23% -1.51% 19.2% 13.28% 6.2% 11.21% 231.43% 98.86% 72.55% 82.14% 47.37% 11.76% 54.55% 57.14% 16.67% 20.0% 25.0% 33.33% 50.0% 100.0% 0.0%
% of Gross Profit 34.92% 30.44% 30.14% 21.52% 19.12% 18.1% 18.17% 19.52% 22.19% 26.16% 28.19% 25.7% 23.05% 23.9% 22.8% 25.03% 27.36% 28.44% 31.48% 35.0% 44.42% 21.84% 18.68% 18.3% 18.27% 25.37% 42.31% 23.33% 25.0% 71.43% 30.77% 60.0% 33.33% 14.29%
Research & Development $2.462B $2.231B $2.501B $3.991B $2.281B $2.597B $2.254B $1.973B $2.013B $1.893B $1.444B $1.335B $1.220B $1.249B $1.283B $1.072B $925.0M $718.0M $748.0M $686.0M $233.0M $101.0M $90.00M $69.00M $43.00M $31.00M $32.00M $28.00M $34.00M $21.00M $19.00M $15.00M $11.00M $10.00M
YoY Change 10.35% -10.8% -37.33% 74.99% -12.19% 15.25% 14.2% -1.96% 6.31% 31.11% 8.18% 9.46% -2.32% -2.68% 19.68% 15.89% 28.83% -4.01% 9.04% 194.42% 130.69% 12.22% 30.43% 60.47% 38.71% -3.13% 14.29% -17.65% 61.9% 10.53% 26.67% 36.36% 10.0% 11.11%
% of Gross Profit 33.72% 28.26% 28.19% 34.29% 18.36% 22.32% 21.17% 19.79% 21.14% 22.19% 23.77% 26.85% 26.62% 28.93% 32.12% 29.0% 32.62% 29.8% 36.51% 41.4% 59.14% 25.06% 32.97% 45.1% 41.35% 46.27% 123.08% 93.33% 141.67% 300.0% 146.15% 300.0% 183.33% 142.86%
Depreciation & Amortization $494.8M $518.4M $487.7M $457.2M $464.7M $650.5M $1.081B $682.7M $600.4M $688.1M $531.7M $365.6M $358.9M $355.7M $428.0M $462.1M $380.3M $375.9M $402.2M $439.4M $61.30M $10.20M $6.300M $4.700M $4.400M $4.300M $4.000M $3.900M $3.100M $2.400M $1.100M $1.000M $400.0K $500.0K
YoY Change -4.55% 6.29% 6.67% -1.61% -28.56% -39.82% 58.34% 13.71% -12.75% 29.42% 45.41% 1.87% 0.91% -16.89% -7.38% 21.51% 1.17% -6.54% -8.47% 616.8% 500.98% 61.9% 34.04% 6.82% 2.33% 7.5% 2.56% 25.81% 29.17% 118.18% 10.0% 150.0% -20.0%
% of Gross Profit 6.78% 6.57% 5.5% 3.93% 3.74% 5.59% 10.16% 6.85% 6.3% 8.06% 8.75% 7.36% 7.83% 8.24% 10.71% 12.5% 13.41% 15.6% 19.63% 26.52% 15.56% 2.53% 2.31% 3.07% 4.23% 6.42% 15.38% 13.0% 12.92% 34.29% 8.46% 20.0% 6.67% 7.14%
Operating Expenses $5.012B $4.635B $5.176B $6.495B $4.655B $4.704B $4.188B $3.920B $4.126B $4.126B $3.156B $2.612B $2.276B $2.280B $2.484B $2.330B $1.959B $1.671B $1.694B $1.614B $441.0M $189.0M $142.0M $97.00M $63.00M $48.00M $44.00M $35.00M $40.00M $26.00M $23.00M $18.00M $13.00M $12.00M
YoY Change 8.13% -10.45% -20.32% 39.53% -1.02% 12.32% 6.83% -4.99% 0.0% 30.72% 20.82% 14.79% -0.19% -8.21% 6.61% 18.94% 17.24% -1.36% 4.96% 265.99% 133.33% 33.1% 46.39% 53.97% 31.25% 9.09% 25.71% -12.5% 53.85% 13.04% 27.78% 38.46% 8.33% 20.0%
Operating Profit $2.291B $3.260B $2.841B $4.550B $7.043B $5.889B $5.346B $5.152B $4.891B $3.972B $2.516B $1.856B $1.725B $1.249B $1.511B $1.366B $877.0M $738.0M $355.0M $43.00M -$47.00M $214.0M $131.0M $56.00M $41.00M $19.00M -$18.00M -$5.000M -$16.00M -$19.00M -$10.00M -$13.00M -$7.000M -$5.000M
YoY Change -29.75% 14.77% -37.57% -35.39% 19.6% 10.15% 3.77% 5.33% 23.12% 57.92% 35.54% 7.6% 38.1% -17.35% 10.61% 55.76% 18.83% 107.89% 725.58% -191.49% -121.96% 63.36% 133.93% 36.59% 115.79% -205.56% 260.0% -68.75% -15.79% 90.0% -23.08% 85.71% 40.0% 25.0%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990
Interest Expense $246.9M $246.6M $253.6M $222.5M $187.4M $200.6M $250.8M $260.0M $95.50M $29.50M $31.90M $36.50M $33.00M $36.10M -$169.0M -$127.0M $69.00M $106.0M $53.00M $38.00M $18.00M $18.00M $31.00M $13.00M $4.000M $3.000M $3.000M $0.00 -$1.000M
YoY Change 0.12% -2.76% 13.98% 18.73% -6.58% -20.02% -3.54% 172.25% 223.73% -7.52% -12.6% 10.61% -8.59% -121.36% 33.07% -284.06% -34.91% 100.0% 39.47% 111.11% 0.0% -41.94% 138.46% 225.0% 33.33% 0.0% -100.0%
% of Operating Profit 10.78% 7.56% 8.93% 4.89% 2.66% 3.41% 4.69% 5.05% 1.95% 0.74% 1.27% 1.97% 1.91% 2.89% -11.18% -9.3% 7.87% 14.36% 14.93% 88.37% 8.41% 23.66% 23.21% 9.76% 15.79%
Other Income/Expense, Net -$315.5M $108.2M -$1.096B $497.4M $83.30M $11.00M -$217.0M -$218.7M -$123.7M -$25.80M -$34.90M -$744.0K -$13.48M -$18.98M $1.000M -$7.000M $7.000M -$4.000M -$33.00M -$18.00M -$29.00M -$1.000M -$1.000M $0.00 $0.00 $0.00 $1.000M $3.000M $1.000M $1.000M
YoY Change -391.59% -109.88% -320.25% 497.12% 657.27% -105.07% -0.78% 76.8% 379.46% -26.07% 4590.86% -94.48% -29.0% -1998.3% -114.29% -200.0% -275.0% -87.88% 83.33% -37.93% 2800.0% 0.0% -100.0% -66.67% 200.0% 0.0% 0.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990
Pretax Income $192.4M $1.842B $448.3M $3.290B $4.725B $3.877B $3.540B $3.655B $3.387B $2.557B $1.953B $1.398B $1.409B $846.4M $1.333B $1.156B $852.0M $492.0M $256.0M $64.00M -$881.0M $232.0M $162.0M $69.00M $46.00M $22.00M -$15.00M -$5.000M -$17.00M -$18.00M -$9.000M -$13.00M -$6.000M -$4.000M
YoY Change -89.55% 310.89% -86.37% -30.37% 21.88% 9.51% -3.15% 7.93% 32.43% 30.95% 39.7% -0.77% 66.46% -36.5% 15.31% 35.68% 73.17% 92.19% 300.0% -107.26% -479.74% 43.21% 134.78% 50.0% 109.09% -246.67% 200.0% -70.59% -5.56% 100.0% -30.77% 116.67% 50.0% 33.33%
Income Tax $135.3M $632.8M $52.50M $992.3M $1.158B $1.426B $2.459B $1.237B $1.162B $989.9M $601.0M $470.6M $444.5M $331.3M $356.0M $366.0M $272.0M $278.0M $95.00M $39.00M -$6.000M $83.00M $60.00M $12.00M $2.000M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 70.32% 34.35% 11.71% 30.16% 24.51% 36.77% 69.45% 33.85% 34.3% 38.71% 30.77% 33.66% 31.55% 39.15% 26.71% 31.66% 31.92% 56.5% 37.11% 60.94% 35.78% 37.04% 17.39% 4.35% 0.0%
Net Earnings $1.161B $3.047B $1.556B $4.001B $5.889B $4.431B $2.539B $3.703B $3.547B $2.935B $1.862B $1.380B $1.234B $1.005B $970.0M $783.0M $638.0M $218.0M $161.0M $25.00M -$875.0M $148.0M $102.0M $48.00M $43.00M $21.00M -$16.00M -$5.000M -$17.00M -$18.00M -$9.000M -$13.00M -$6.000M -$4.000M
YoY Change -61.89% 95.8% -61.1% -32.06% 32.9% 74.5% -31.43% 4.39% 20.86% 57.59% 34.95% 11.8% 22.8% 3.64% 23.88% 22.73% 192.66% 35.4% 544.0% -102.86% -691.22% 45.1% 112.5% 11.63% 104.76% -231.25% 220.0% -70.59% -5.56% 100.0% -30.77% 116.67% 50.0% 33.33%
Net Earnings / Revenue 11.81% 29.95% 14.17% 29.76% 40.96% 32.93% 20.69% 32.34% 32.95% 30.25% 26.86% 25.02% 24.45% 21.31% 22.16% 19.11% 20.11% 8.13% 6.64% 1.13% -128.87% 36.63% 37.36% 30.97% 36.44% 24.14% -35.56% -16.67% -70.83% -257.14% -69.23% -260.0% -100.0% -57.14%
Basic Earnings Per Share $8.02 $20.96 $10.44 $24.86 $31.47 $21.63 $11.94 $16.96 $15.38 $12.42 $7.86 $5.80 $5.09 $3.98
Diluted Earnings Per Share $7.97 $20.87 $10.40 $24.80 $31.42 $21.58 $11.92 $16.93 $15.34 $12.37 $7.81 $5.76 $5.04 $3.94 $3.356M $2.654M $1.994M $631.9K $465.3K $72.89K -$4.916M $822.2K $563.5K $301.9K $284.8K $150.0K -$142.9K -$50.51K -$193.2K -$272.7K -$160.7K -$236.4K -$153.8K -$133.3K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990
Cash & Short-Term Investments $1.050B $4.893B $3.803B $2.610B $4.476B $3.538B $3.689B $4.895B $3.429B $1.845B $1.223B $1.706B $1.691B $1.208B $1.264B $1.371B $1.184B $903.0M $851.0M $1.058B $836.0M $788.0M $624.0M $581.0M $246.0M $74.00M $70.00M $79.00M $24.00M $21.00M $27.00M $38.00M $39.00M
YoY Change -78.54% 28.67% 45.69% -41.69% 26.51% -4.09% -24.64% 42.75% 85.85% 50.86% -28.31% 0.89% 39.98% -4.43% -7.8% 15.79% 31.12% 6.11% -19.57% 26.56% 6.09% 26.28% 7.4% 136.18% 232.43% 5.71% -11.39% 229.17% 14.29% -22.22% -28.95% -2.56%
Cash & Equivalents $1.050B $3.419B $2.261B $1.331B $2.914B $1.225B $1.574B $2.327B $1.308B $1.205B $603.0M $571.0M $515.0M $760.0M $582.0M $622.0M $660.0M $661.0M $568.0M $209.0M $315.0M $350.0M $426.0M $401.0M $61.00M $27.00M $35.00M $25.00M $19.00M $14.00M $10.00M $5.000M $12.00M
Short-Term Investments $0.00 $1.474B $1.541B $1.279B $1.562B $2.313B $2.115B $2.569B $2.121B $641.0M $620.0M $1.135B $1.176B $448.0M $682.0M $749.0M $524.0M $241.0M $283.0M $848.0M $521.0M $438.0M $198.0M $180.0M $185.0M $47.00M $35.00M $53.00M $5.000M $7.000M $17.00M $34.00M $27.00M
Other Short-Term Assets $1.182B $1.418B $740.8M $881.0M $631.0M $688.0M $963.0M $1.093B $837.0M $310.0M $226.0M $136.0M $145.0M $203.0M $162.0M $155.0M $367.0M $104.0M $145.0M $206.0M $191.0M $51.00M $16.00M $6.000M $5.000M $2.000M $1.000M $3.000M $1.000M $1.000M $1.000M $1.000M $1.000M
YoY Change -16.62% 91.36% -15.91% 39.62% -8.28% -28.56% -11.89% 30.59% 170.0% 37.17% 66.18% -6.21% -28.57% 25.31% 4.52% -57.77% 252.88% -28.28% -29.61% 7.85% 274.51% 218.75% 166.67% 20.0% 150.0% 100.0% -66.67% 200.0% 0.0% 0.0% 0.0% 0.0%
Inventory $2.527B $1.344B $1.352B $1.069B $804.0M $930.0M $903.0M $1.002B $893.0M $804.0M $659.0M $447.0M $327.0M $289.0M $294.0M $264.0M $234.0M $169.0M $183.0M $251.0M $496.0M $34.00M $1.000M $0.00 $2.000M $5.000M $4.000M $4.000M $0.00 $0.00 $0.00 $1.000M $1.000M
Prepaid Expenses
Receivables $2.100B $2.136B $1.962B $2.327B $2.471B $2.485B $2.320B $1.742B $1.542B $1.576B $1.077B $955.0M $813.0M $828.0M $745.0M $654.0M $559.0M $486.0M $422.0M $416.0M $316.0M $105.0M $69.00M $43.00M $25.00M $20.00M $4.000M $4.000M $1.000M $1.000M $0.00 $0.00 $0.00
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $12.00M $16.00M $13.00M $25.00M $50.00M $32.00M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.000M $0.00 $1.000M $0.00 $1.000M
Total Short-Term Assets $6.859B $9.791B $7.857B $6.887B $8.382B $7.641B $7.873B $8.732B $6.700B $4.535B $3.185B $3.244B $2.975B $2.540B $2.481B $2.458B $2.368B $1.713B $1.633B $1.931B $1.839B $978.0M $709.0M $631.0M $279.0M $101.0M $79.00M $91.00M $27.00M $23.00M $28.00M $41.00M $42.00M
YoY Change -29.94% 24.63% 14.08% -17.84% 9.7% -2.95% -9.84% 30.33% 47.74% 42.39% -1.82% 9.04% 17.13% 2.38% 0.94% 3.8% 38.24% 4.9% -15.43% 5.0% 88.04% 37.94% 12.36% 126.16% 176.24% 27.85% -13.19% 237.04% 17.39% -17.86% -31.71% -2.38%
Property, Plant & Equipment $3.730B $3.703B $3.792B $3.845B $3.674B $3.601B $3.182B $2.502B $2.188B $1.766B $1.751B $1.742B $1.571B $1.642B $1.637B $1.595B $1.497B $1.280B $1.174B $1.525B $1.253B $265.0M $109.0M $48.00M $21.00M $21.00M $23.00M $21.00M $18.00M $19.00M $20.00M $3.000M $1.000M
YoY Change 0.73% -2.36% -1.38% 4.65% 2.03% 13.17% 27.18% 14.35% 23.9% 0.86% 0.52% 10.88% -4.32% 0.31% 2.63% 6.55% 16.95% 9.03% -23.02% 21.71% 372.83% 143.12% 127.08% 128.57% 0.0% -8.7% 9.52% 16.67% -5.26% -5.0% 566.67% 200.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $745.0M $2.235B $2.832B $3.671B $2.654B $3.039B $4.056B $4.159B $3.868B $2.223B $1.220B $2.311B $1.748B $991.0M $1.424B $1.127B $1.133B $1.658B $1.468B $1.266B $1.502B $660.0M $243.0M $169.0M $0.00 $0.00 $1.000M $2.000M $0.00 $5.000M $15.00M
YoY Change -66.67% -21.07% -22.87% 38.32% -12.67% -25.07% -2.48% 7.52% 74.0% 82.21% -47.21% 32.21% 76.39% -30.41% 26.35% -0.53% -31.66% 12.94% 15.96% -15.71% 127.58% 171.6% 43.79% -100.0% -50.0% -100.0% -66.67%
Other Assets $928.6M $1.226B $1.415B $1.370B $3.239B $2.182B $29.00M $7.000M $0.00 $2.000M $0.00 $120.0M $148.0M $81.00M $8.000M $8.000M $3.000M $3.000M $1.000M $0.00 $0.00 $1.000M $0.00 $0.00
YoY Change -24.28% -13.33% 3.29% -57.7% 48.44% 7424.14% 314.29% -100.0% -18.92% 82.72% 912.5% 0.0% 166.67% 0.0% 200.0% -100.0%
Total Long-Term Assets $19.99B $14.76B $16.02B $17.73B $18.85B $17.65B $15.78B $14.15B $12.81B $9.780B $8.678B $6.886B $6.075B $5.552B $6.071B $6.021B $6.261B $6.840B $6.749B $7.235B $7.665B $1.082B $432.0M $225.0M $28.00M $24.00M $27.00M $22.00M $21.00M $22.00M $23.00M $12.00M $16.00M
YoY Change 35.38% -7.85% -9.65% -5.94% 6.82% 11.84% 11.56% 10.46% 30.93% 12.7% 26.02% 13.35% 9.42% -8.55% 0.83% -3.83% -8.46% 1.35% -6.72% -5.61% 608.41% 150.46% 92.0% 703.57% 16.67% -11.11% 22.73% 4.76% -4.55% -4.35% 91.67% -25.0%
Total Assets $26.84B $24.55B $23.88B $24.62B $27.23B $25.29B $23.65B $22.88B $19.51B $14.32B $11.86B $10.13B $9.050B $8.092B $8.552B $8.479B $8.629B $8.553B $8.382B $9.166B $9.504B $2.060B $1.141B $856.0M $307.0M $125.0M $106.0M $113.0M $48.00M $45.00M $51.00M $53.00M $58.00M
YoY Change
Accounts Payable $403.3M $491.5M $589.2M $455.0M $531.0M $371.0M $396.0M $280.0M $267.0M $229.0M $220.0M $204.0M $186.0M $163.0M $119.0M $107.0M $91.00M $100.0M $100.0M $121.0M $63.00M $4.000M $4.000M $2.000M $1.000M $2.000M $2.000M $3.000M $1.000M $3.000M $7.000M $4.000M $1.000M
YoY Change -17.95% -16.58% 29.49% -14.31% 43.13% -6.31% 41.43% 4.87% 16.59% 4.09% 7.84% 9.68% 14.11% 36.97% 11.21% 17.58% -9.0% 0.0% -17.36% 92.06% 1475.0% 0.0% 100.0% 100.0% -50.0% 0.0% -33.33% 200.0% -66.67% -57.14% 75.0% 300.0%
Accrued Expenses $2.624B $1.497B $1.471B $1.716B $1.683B $1.546B $1.236B $1.506B $1.101B $1.050B $769.0M $485.0M $263.0M $482.0M $462.0M $535.0M $368.0M $337.0M $298.0M $248.0M $240.0M $52.00M $28.00M $16.00M $13.00M $10.00M $6.000M $6.000M $4.000M $2.000M $3.000M $4.000M $1.000M
YoY Change 75.3% 1.74% -14.28% 1.96% 8.86% 25.08% -17.93% 36.78% 4.86% 36.54% 58.56% 84.41% -45.44% 4.33% -13.64% 45.38% 9.2% 13.09% 20.16% 3.33% 361.54% 85.71% 75.0% 23.08% 30.0% 66.67% 0.0% 50.0% 100.0% -33.33% -25.0% 300.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $150.0M $0.00 $999.1M $0.00 $1.496B $0.00 $3.000M $5.000M $5.000M $3.000M $3.000M $453.0M $3.000M $137.0M $20.00M $28.00M $1.511B $0.00 $748.0M $0.00 $1.000M $2.000M $2.000M $4.000M $4.000M $3.000M $4.000M $1.000M $0.00 $0.00
YoY Change -100.0% -100.0% -100.0% -40.0% 0.0% 66.67% 0.0% -99.34% 15000.0% -97.81% 585.0% -28.57% -98.15% -50.0% 0.0% -50.0% 0.0% 33.33% -25.0% 300.0%
Total Short-Term Liabilities $3.434B $3.273B $4.298B $3.742B $4.864B $3.295B $3.368B $3.420B $2.578B $2.218B $1.758B $1.657B $913.0M $1.050B $715.0M $923.0M $2.189B $583.0M $598.0M $1.261B $405.0M $56.00M $34.00M $23.00M $16.00M $14.00M $19.00M $13.00M $9.000M $9.000M $11.00M $9.000M $2.000M
YoY Change 4.93% -23.86% 14.86% -23.07% 47.62% -2.17% -1.52% 32.66% 16.23% 26.17% 6.1% 81.49% -13.05% 46.85% -22.54% -57.83% 275.47% -2.51% -52.58% 211.36% 623.21% 64.71% 47.83% 43.75% 14.29% -26.32% 46.15% 44.44% 0.0% -18.18% 22.22% 350.0%
Long-Term Debt $6.788B $6.281B $6.274B $7.426B $4.459B $5.937B $5.935B $6.513B $6.522B $580.0M $592.0M $687.0M $1.061B $1.066B $1.080B $1.085B $52.00M $97.00M $43.00M $102.0M $887.0M $866.0M $136.0M $129.0M $123.0M $2.000M $4.000M $5.000M $7.000M $7.000M $4.000M $0.00 $0.00
YoY Change 8.08% 0.11% -15.51% 66.54% -24.89% 0.03% -8.87% -0.14% 1024.48% -2.03% -13.83% -35.25% -0.47% -1.3% -0.46% 1986.54% -46.39% 125.58% -57.84% -88.5% 2.42% 536.76% 5.43% 4.88% 6050.0% -50.0% -20.0% -28.57% 0.0% 75.0%
Other Long-Term Liabilities $1.181B $1.277B $1.651B $1.732B $1.762B $1.389B $1.629B $723.0M $906.0M $650.0M $659.0M $604.0M $400.0M $326.0M $254.0M $280.0M $332.0M $80.00M $72.00M $55.00M $50.00M $28.00M $15.00M $4.000M $9.000M $2.000M $2.000M $3.000M $1.000M $1.000M $0.00 $0.00 $1.000M
YoY Change -7.52% -22.64% -4.68% -1.7% 26.85% -14.73% 125.31% -20.2% 39.38% -1.37% 9.11% 51.0% 22.7% 28.35% -9.29% -15.66% 315.0% 11.11% 30.91% 10.0% 78.57% 86.67% 275.0% -55.56% 350.0% 0.0% -33.33% 200.0% 0.0% -100.0%
Total Long-Term Liabilities $7.969B $7.558B $7.925B $9.158B $6.221B $7.326B $7.564B $7.236B $7.428B $1.230B $1.251B $1.291B $1.461B $1.392B $1.334B $1.365B $384.0M $177.0M $115.0M $157.0M $937.0M $894.0M $151.0M $133.0M $132.0M $4.000M $6.000M $8.000M $8.000M $8.000M $4.000M $0.00 $1.000M
YoY Change 5.44% -4.63% -13.46% 47.21% -15.08% -3.15% 4.53% -2.58% 503.9% -1.68% -3.1% -11.64% 4.96% 4.35% -2.27% 255.47% 116.95% 53.91% -26.75% -83.24% 4.81% 492.05% 13.53% 0.76% 3200.0% -33.33% -25.0% 0.0% 0.0% 100.0% -100.0%
Total Liabilities $12.05B $11.16B $12.98B $13.92B $13.89B $12.25B $11.04B $10.74B $10.13B $3.506B $3.243B $3.169B $2.624B $2.696B $2.330B $2.673B $3.095B $1.403B $1.476B $2.339B $2.451B $950.0M $185.0M $162.0M $147.0M $19.00M $25.00M $20.00M $16.00M $18.00M $15.00M $9.000M $4.000M
YoY Change 7.97% -14.06% -6.74% 0.2% 13.41% 10.95% 2.82% 5.97% 188.99% 8.11% 2.34% 20.77% -2.67% 15.71% -12.83% -13.63% 120.6% -4.95% -36.9% -4.57% 158.0% 413.51% 14.2% 10.2% 673.68% -24.0% 25.0% 25.0% -11.11% 20.0% 66.67% 125.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $23.449 Billion

About BIOGEN INC.

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 7,570 full-time employees. The company has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). The company is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. The Company’s marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS; and FUMADERM for the treatment of severe plaque psoriasis. The company also has collaborations for the commercialization of LEQEMBI, ZURZUVAE, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS, LUNSUMIO, and COLUMVI. The company commercializes a portfolio of biosimilars of advanced biologics including BENEPALI, IMRALDI, FLIXABI, and BYOOVIZ.

Industry: Biological Products, (No Diagnostic Substances) Peers: ALNYLAM PHARMACEUTICALS, INC. BIOMARIN PHARMACEUTICAL INC GILEAD SCIENCES, INC. INCYTE CORP Moderna, Inc. REGENERON PHARMACEUTICALS, INC. Seagen Inc. VERTEX PHARMACEUTICALS INC / MA